Roy Geronemus, MD, clinical professor of dermatology at New York University Medical Center & Dermatology Times editorial advisory board member, discusses the recent FDA clearance of ellacor Micro-Coring Technology for treatment of moderate to severe wrinkles in the mid to lower face.
Shino Bay Aguilera, DO, reflects on his keynote address highlighting diversity and wellness in aesthetic medicine at Aesthetics Biomedical’s “Perspectives: The Evolution of Aesthetics” symposium.
Mark Lebwohl, MD, explains the recent delay in approval of JAK inhibitors by the FDA, how it is affecting the inflammatory skin disease community, and if physicians should be concerned.
In this video interview, Jerry Bagel, MD, MS, discusses improvement in quality of life for pediatric psoriasis patients and current and emerging treatments.
In this video interview, David Light, CEO of Valisure, shares his thoughts on the recent sunscreen recall from Johnson & Johnson due to benzene contamination and reveals how the FDA and sun protection companies can make sure this never happens again.
Joshua Zeichner, MD, associate professor of dermatology and director of cosmetic & clinical research in dermatology, Mount Sinai Hospital, New York, discusses the impact of the recent FDA approval of Twyneo (Sol-Gel) for the treatment of acne.
Shino Bay Aguilera, DO, reflects on his keynote address highlighting diversity and wellness in aesthetic medicine at Aesthetics Biomedical’s “Perspectives: The Evolution of Aesthetics” symposium.
In this video interview, Alberto Pappo, MD, director, St. Jude Solid Tumor Division, discusses a registry he helped create aimed at helping physicians better understand pediatric melanoma called Molecular Analysis of Childhood MELanocytic Tumors (MACMEL).
In this exclusive video interview, Christopher Bunick, MD, PhD, gives Dermatology Times an update on benzene contamination being detected in various sunscreens and after-sun care products, as well as a recent recall by Johnson & Johnson.
In this monthly technology review, Michael Kluska, DO, and Chad Deal, MD, discuss the EON by Dominion Aesthetic Technologies, including device specifics, cost, and ROI.
Take a look inside Suneel Chilukuri, MDs, Refresh Dermatology practice as he discusses patient retention and demonstrates his QWO cellulite treatment protocol in office.
Suneel Chilukuri, MD, FAAD, FACMAS, takes Dermatology Times inside his practice, Refresh Dermatology located in Houston, Texas, to demonstrate how they separate themselves from competitors.
Klint Peebles, MD, FAAD, co-chair of the AAD LGBTQ/GSM Expert Resource Group, tips and resources for maintaining your mental health as a gender and sexual minority.
In this video interview, Ted Lain, MD, discusses the causes and effects of actinic keratosis, as well as the unmet needs, how to diagnose, and what treatments are currently available.
In this exclusive interview, Ted Lain, MD, dives into the management of field cancerization, including its biggest challenges, available and emerging treatment options, tips on treatment approach, and more.
John Browning, MD, FAAD, FAAP, MBA, discusses the impact of the recent FDA approval of secukinumab (Cosentyx, Novartis) for the treatment of moderate to severe plaque psoriasis in children and adolescents.
Emma Guttman-Yassky, MD, sits down with Dermatology Times® to discuss recently published results of a phase 3 study evaluating upadacitinib (Rinvoq, AbbVie) as a potential treatment of atopic dermatitis.
In this video interview, Klint Peebles, MD, FAAD, co-chair of the AAD LGBTQ/GSM Expert Resource Group, dives into the impacts health care policies such as the Affordable Care Act and Medicaid expansion have on gender and sexual minority patients.
Klint Peebles, MD, FAAD, co-chair of the AAD LGBTQ/GSM Expert Resource Group, discusses how to provide the best care for your gender and sexual minority patients.
Christopher Bunick, MD, PhD, associate professor of dermatology, Yale University and Dermatology Times® editorial advisory board member, weighs in on a recent report revealing certain batches of various sunscreen and after-sun care products were contaminated with benzene, a carcinogen.
David Light, founder and CEO of Valisure, the independent lab that discovered the presence of a human carcinogen in multiple brands and batches of sunscreen, sits down with Aesthetic Authority discuss the reports' findings and the impact this news will have on the sun protection industry.
David Light, founder and CEO of Valisure, the independent lab that discovered the presence of benzene in multiple brands and batches of sunscreen, sits down with Dermatology Times to discuss the reports' findings and the impact this news will have on the sun protection industry.
In this monthly technology review, Michael Kluska, DO, discusses Evoke by InMode, including cost, ROI, patient protocols, and treatment frequency.
Ava Shamban, MD, discusses microneedling differentiators using the Vivace Microneedle RF device, combination therapies, and the importance of social media partnerships.
In part two of our interview with Misha Rosenbach, MD, he reveals what kind of skin manifestations are on the rise due to global warming and how dermatologists can help fight against climate change.
Misha Rosenbach, MD, discusses the effects climate change has on dermatology and how using social media can help spread awareness.
In the final part of our interview with Hilary Baldwin, MD, she details her own personal account of how she handled her daughters' acne and her advice to other dermatologists who are also parents.
In part 2 of our exclusive video interview with Hilary Baldwin, MD, she discusses new treatments for acne and how to ensure compliance of these treatments among your young patients.
In part 1 of this video interview, Hilary Baldwin, MD, explains her findings from a recently conducted survey investigating the effects of acne on both teenagers and their parents.
Mark Lebwohl, MD, discusses his recent presentation from AAD VMX 2021 regarding new data for various biologics for the treatment of psoriasis.
